RNA, U6 small nuclear 109, pseudogene (RNU6-109P)

RNA, U6 small nuclear 109, pseudogene (RNU6-109P) is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene family in humans[1][5][6]. U6 snRNA genes are key components of the spliceosome and play essential roles in pre-mRNA splicing[4]. However, RNU6-109P is a pseudogene, meaning it is a non-functional genomic DNA segment that resembles its functional counterparts but generally does not produce an active RNA or protein product[1][5][6]. Most U6 snRNA pseudogenes are generated by retrotransposition and do not encode any functional product nor participate in splicing[5]. As such, RNU6-109P is not considered a relevant biological target, has no known therapeutic implications, and is not associated with any disease roles, drugs, biomarkers, or safety issues[1][5][6]. There is no evidence of a specific biological function, biomarker use, or disease relevance for this pseudogene. Note: - RNU6-109P is a pseudogene and **not a therapeutic target, receptor, enzyme, or functional gene**[1][6]. - The entry is correct in terms of gene annotation, but it is not suitable for therapeutic or functional target collection, making **is_incorrect: true** for purposes where only active molecular targets are desired. - There are multiple U6 snRNA pseudogenes, and they are frequently annotated by automated pipelines without confirmed biological relevance[5][6].

Other names

RNU6-109P